R&D Systems™ Recombinant Human IFN-epsilon Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IFN-epsilon Protein is derived from E. coli. The Recombinant Human IFN-epsilon Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q86WN2
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in Citric Acid and CHAPS with BSA as a carrier protein.
• Gene ID (Entrez): 338376
• Molecular Weight (g/mol): 23 kDa
• Name: IFNE, IFN-E, IFNE1PRO655, IFNepsilon, IFN-epsilon, IFNT1, Ifn-tau-11, INFE1, interferon epsilon, interferon epsilon 1, Interferon epsilon-1, interferon tau-1, interferon, epsilon, interferon-epsilon, MGC119018, MGC119020
• Quantity: 25 μg
• Source: E. coli-derived human IFN-epsilon protein Leu22-Arg208 (Cys175Ser),with an N-terminal Met and a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 250μg/mL in water.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.